|Bid||33.230 x 9500|
|Ask||33.240 x 8000|
|Day's Range||33.170 - 33.480|
|52 Week Range||29.830 - 37.390|
|PE Ratio (TTM)||28.01|
|Dividend & Yield||1.28 (3.82%)|
|1y Target Est||N/A|
In 2016, Pfizer’s (PFE) Sutent reported revenues of ~$1.1 billion, which represented a ~2% decline on a YoY (year-over-year) basis.
In 2016, Pfizer’s (PFE) Prevnar 13 reported revenues of ~$5.7 billion, which reflected a ~8% decline on a YoY (year-over-year) basis.
In 2016, Pfizer’s (PFE) Xeljanz reported revenues of ~$927 million, which reflected a ~77% growth YoY (year-over-year).